- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Sierra Oncology (NASDAQ:SRRA), Quotes and News Summary
Sierra Oncology (NASDAQ: SRRA)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.030 | -1.330 | -0.3000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Sierra Oncology Questions & Answers
You can purchase shares of Sierra Oncology (NASDAQ: SRRA) through any online brokerage.
Other companies in Sierra Oncology’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Prothena Corp (NASDAQ:PRTA), CareDx (NASDAQ:CDNA) and Xencor (NASDAQ:XNCR).
The latest price target for Sierra Oncology (NASDAQ: SRRA) was reported by Jefferies on Thursday, April 14, 2022. The analyst firm set a price target for 55.00 expecting SRRA to rise to within 12 months (a possible 0.58% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Sierra Oncology (NASDAQ: SRRA) is $54.685 last updated Today at May 20, 2022, 2:45 PM UTC.
There are no upcoming dividends for Sierra Oncology.
Sierra Oncology’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Sierra Oncology.
Sierra Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.